Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey

Abstract Introduction The COVID‐19 pandemic has forced rapid reconsideration as to the way in which health care is delivered. One potential means to provide care while avoiding unnecessary person‐to‐person contact is to offer remote services (telemedicine). This study aimed to (1) gather real‐time i...

Full description

Bibliographic Details
Main Authors: Sam N. Scott, Federico Y. Fontana, Thomas Züger, Markus Laimer, Christoph Stettler
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
Online Access:https://doi.org/10.1002/edm2.180
id doaj-e7a237fddcda45bbab8aa7800b39a581
record_format Article
spelling doaj-e7a237fddcda45bbab8aa7800b39a5812021-02-23T04:16:24ZengWileyEndocrinology, Diabetes & Metabolism2398-92382021-01-0141n/an/a10.1002/edm2.180Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global surveySam N. Scott0Federico Y. Fontana1Thomas Züger2Markus Laimer3Christoph Stettler4Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism Bern University Hospital University of Bern Bern SwitzerlandTeam Novo Nordisk Professional Cycling Team Atlanta GA USADepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism Bern University Hospital University of Bern Bern SwitzerlandDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism Bern University Hospital University of Bern Bern SwitzerlandDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism Bern University Hospital University of Bern Bern SwitzerlandAbstract Introduction The COVID‐19 pandemic has forced rapid reconsideration as to the way in which health care is delivered. One potential means to provide care while avoiding unnecessary person‐to‐person contact is to offer remote services (telemedicine). This study aimed to (1) gather real‐time information on the use and perception of telemedicine in people living with type 1 diabetes and (2) assess the challenges, such as restricted access to health care and/or medical supplies. Methods An anonymous questionnaire was widely distributed between 24 March and 5 May 2020 using an open‐access web‐based platform. Data were analysed descriptively, and results were stratified according to age, sex and HbA1c. Results There were 7477 survey responses from individuals in 89 countries. Globally, 30% reported that the pandemic had affected their healthcare access due to cancelled physical appointments with their healthcare providers. Thirty‐two per cent reported no fundamental change in their medical follow‐up during this period, with 9% stating that no personal contact was established with their doctors over the duration of the study. Twenty‐eight per cent received remote care through telephone (72%) or video‐calls (28%). Of these, 86% found remote appointments useful and 75% plan to have remote appointments in the future. Glucose control, indicated by HbA1c, was positively associated with positive perception of telemedicine. In males, 45% of respondents with an HbA1c > 9% rated telemedicine not useful compared to those with lower HbA1c, while 20% of females with an HbA1c > 9% rated it not useful (χ2 = 14.2, P = .0016). Conclusion Remote appointments have largely been perceived as positive in people with type 1 diabetes with the majority (75%) stating that they would consider remote appointments beyond the pandemic. Age and level of education do not appear to influence perception of telemedicine, whereas poor glucose control, particularly in males, seems to negatively affect perception.https://doi.org/10.1002/edm2.180COVID‐19telemedicinetype 1 diabetes
collection DOAJ
language English
format Article
sources DOAJ
author Sam N. Scott
Federico Y. Fontana
Thomas Züger
Markus Laimer
Christoph Stettler
spellingShingle Sam N. Scott
Federico Y. Fontana
Thomas Züger
Markus Laimer
Christoph Stettler
Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey
Endocrinology, Diabetes & Metabolism
COVID‐19
telemedicine
type 1 diabetes
author_facet Sam N. Scott
Federico Y. Fontana
Thomas Züger
Markus Laimer
Christoph Stettler
author_sort Sam N. Scott
title Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey
title_short Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey
title_full Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey
title_fullStr Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey
title_full_unstemmed Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey
title_sort use and perception of telemedicine in people with type 1 diabetes during the covid‐19 pandemic—results of a global survey
publisher Wiley
series Endocrinology, Diabetes & Metabolism
issn 2398-9238
publishDate 2021-01-01
description Abstract Introduction The COVID‐19 pandemic has forced rapid reconsideration as to the way in which health care is delivered. One potential means to provide care while avoiding unnecessary person‐to‐person contact is to offer remote services (telemedicine). This study aimed to (1) gather real‐time information on the use and perception of telemedicine in people living with type 1 diabetes and (2) assess the challenges, such as restricted access to health care and/or medical supplies. Methods An anonymous questionnaire was widely distributed between 24 March and 5 May 2020 using an open‐access web‐based platform. Data were analysed descriptively, and results were stratified according to age, sex and HbA1c. Results There were 7477 survey responses from individuals in 89 countries. Globally, 30% reported that the pandemic had affected their healthcare access due to cancelled physical appointments with their healthcare providers. Thirty‐two per cent reported no fundamental change in their medical follow‐up during this period, with 9% stating that no personal contact was established with their doctors over the duration of the study. Twenty‐eight per cent received remote care through telephone (72%) or video‐calls (28%). Of these, 86% found remote appointments useful and 75% plan to have remote appointments in the future. Glucose control, indicated by HbA1c, was positively associated with positive perception of telemedicine. In males, 45% of respondents with an HbA1c > 9% rated telemedicine not useful compared to those with lower HbA1c, while 20% of females with an HbA1c > 9% rated it not useful (χ2 = 14.2, P = .0016). Conclusion Remote appointments have largely been perceived as positive in people with type 1 diabetes with the majority (75%) stating that they would consider remote appointments beyond the pandemic. Age and level of education do not appear to influence perception of telemedicine, whereas poor glucose control, particularly in males, seems to negatively affect perception.
topic COVID‐19
telemedicine
type 1 diabetes
url https://doi.org/10.1002/edm2.180
work_keys_str_mv AT samnscott useandperceptionoftelemedicineinpeoplewithtype1diabetesduringthecovid19pandemicresultsofaglobalsurvey
AT federicoyfontana useandperceptionoftelemedicineinpeoplewithtype1diabetesduringthecovid19pandemicresultsofaglobalsurvey
AT thomaszuger useandperceptionoftelemedicineinpeoplewithtype1diabetesduringthecovid19pandemicresultsofaglobalsurvey
AT markuslaimer useandperceptionoftelemedicineinpeoplewithtype1diabetesduringthecovid19pandemicresultsofaglobalsurvey
AT christophstettler useandperceptionoftelemedicineinpeoplewithtype1diabetesduringthecovid19pandemicresultsofaglobalsurvey
_version_ 1724255191034757120